Overview

  • Product name
    Anti-KSHV ORF45 antibody [2D4A5]
  • Description
    Mouse monoclonal [2D4A5] to KSHV ORF45
  • Tested applications
    Suitable for: WB, ELISAmore details
  • Species reactivity
    Kaposi's sarcoma herpes virus
  • Immunogen

    Ni-NTA purified recombinant human KSHV ORF45 expressed in E. Coli strain BL21 (DE3).

  • Positive control
    • TPA induced BCBL-1 cells.

Properties

  • Form
    Liquid
  • Storage instructions
    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • Storage buffer
    Preservative: 0.05% Sodium azide
    Constituent: PBS
  • Concentration information loading...
  • Purity
    Protein G purified
  • Purification notes
    Purified from tissue culture supernatant.
  • Clonality
    Monoclonal
  • Clone number
    2D4A5
  • Isotype
    IgG1
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab36618 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/500 - 1/1000. Detects a band of approximately 78 kDa (predicted molecular weight: 50 kDa).
ELISA Use at an assay dependent dilution.

Target

  • Relevance
    Kaposi's sarcoma-associated herpes virus (KSHV) belongs to the gamma-herpesvirus subfamily of the Herpes viridae family and has been closely linked to the Kaposi's sarcoma, primary effusion lymphoma (PEL) and multicentric Castleman's disease. The genome of KSHV is 165-170 kb and contains at least 88 open reading frames. ORF45 protein encoded by an immediate-early gene in the KSHV genome is characterized as a phosphorylated protein, and it is localized in the cytoplasm of infected cells. Studies have shown that ORF45 Protein interacted with cellular IRF-7 and blocked virus-mediated phosphorylation and nuclear translocation of IRF-7. In consequence, ORF45 efficiently inhibited virus-induced production of type I IFN. Zhu et al (2003) reported that the ORF45 Protein was associated with purified virions.
  • Cellular localization
    Not applicable
  • Alternative names
    • HHV8 antibody
    • Human herpes virus 8 antibody
    • Kaposi's sarcoma herpes virus antibody
    • KSHV antibody
    • ORF45 antibody
    see all

Anti-KSHV ORF45 antibody [2D4A5] images

  • All lanes : Anti-KSHV ORF45 antibody [2D4A5] (ab36618)

    Lane 1 : Molecular weight marker
    Lane 2 : Recombinant KSHV ORF45 expressed in E.coli


    Predicted band size : 50 kDa
    Observed band size : 78 kDa (why is the actual band size different from the predicted?)
    Based on the analysis of the mRNA sequence, ORF45 is expected to encode a protein of 407 amino acids with a molecular mass of about 50 kDa. However, ORF45 was displayed as a diffuse band at the position of 78 kDa on a Western blot after SDS-PAGE. This observation implied that ORF45 might be highly post-translationally modified, resulting in its reduced mobility in denaturing SDS-PAGE. A survey of the primary amino acid sequence of ORF45 revealed multiple potential sites of phosphorylation, including a serine-rich region and other consensus sites for phosphorylation by the serine/threonine kinase, casein kinase II, and protein kinase C (Zhu & Yuan, 2003).
  • Immunochemistry staining of TPA-induced BCBL-1 cells, using ab36618. HRP-anti-mouse was used as the secondary antibody before colour development with DAB.

References for Anti-KSHV ORF45 antibody [2D4A5] (ab36618)

This product has been referenced in:
  • Abada R  et al. SIAH-1 interacts with the Kaposi's sarcoma-associated herpesvirus-encoded ORF45 protein and promotes its ubiquitylation and proteasomal degradation. J Virol 82:2230-40 (2008). WB . Read more (PubMed: 18077711) »

See 1 Publication for this product

Product Wall

There are currently no Abreviews or Questions for ab36618.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up